Trexquant Investment LP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1633445 STAMFORD, CT

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$26,088,290

+$17,533,620 QoQ

Shares Held

41,839

+277.9% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#178

of 1,297 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. REGN ranks #2 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	505,160	$35,376,354
2	REGN	Regeneron Pharmaceuticals, Inc. This page	41,839	$26,088,290
3	RVMD	Revolution Medicines, Inc.	120,122	$22,496,448
4	AXSM	Axsome Therapeutics, Inc.	83,679	$20,482,108
5	RARE	Ultragenyx Pharmaceutical Inc.	556,385	$18,577,695
6	INSM	INSMED Inc	156,553	$16,691,680
7	SRRK	Scholar Rock Holding Corp	275,712	$15,164,160
8	EXEL	Exelixis, Inc.	275,209	$14,974,121

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,088,290	41,839	+277.9%	Shares	Sole	2026-08-14
2026-03-31	$8,554,670	11,072	+225.4%	Shares	Sole	2026-05-15
2025-12-31	$2,626,673	3,403	-71.5%	Shares	Sole	2026-02-17
2025-06-30	$6,266,400	11,936	-79.0%	Shares	Sole	2025-08-12
2025-03-31	$36,107,348	56,931	+0.5%	Shares	Sole	2025-05-14
2024-12-31	$40,335,686	56,625	+305.9%	Shares	Sole	2025-02-12
2024-09-30	$14,665,849	13,951	+136.8%	Shares	Sole	2024-11-12
2023-12-31	$5,174,006	5,891	+164.2%	Shares	Sole	2024-02-09
2021-12-31	$1,408,289	2,230	-79.5%	Shares	Sole	2022-02-14
2021-09-30	$6,569,228	10,855	+192.0%	Shares	Sole	2021-11-12
2020-12-31	$1,795,719	3,717	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.